Rhodococcus erythropolis as a host for expression, secretion and glycosylation of Mycobacterium tuberculosis proteins
© The Author(s) 2017
Received: 24 August 2016
Accepted: 10 January 2017
Published: 19 January 2017
Glycosylation is one of the most abundant posttranslational polypeptide chain modification in nature. Although carbohydrate modification of protein antigens from many microbial pathogens constitutes important components of B cell epitopes, the role in T cell immunity is not completely understood. There is growing evidence about the importance of these modifications in host bacteria interactions in tuberculosis. It is known, that the sugars present in some Mycobacterium tuberculosis glycoproteins play an important role in both humoral and cellular immune response against the pathogen. Since this modification is lost in the recombinant proteins expressed in Escherichia coli, it is fundamental to search for host bacteria with the capacity to modify the foreign proteins. Amongst the bacteria that are likely to have this possibility are some members of Rhodococcus genus which are Gram-positive bacteria, with high GC-content and genetically very close related to M. tuberculosis.
In this work, apa, pstS1 and lprG genes that coding for M. tuberculosis glycoproteins were cloned and expressed in Rhodococcus erythropolis. All recombinant proteins were mannosylated as demonstrated by their interaction with mannose binding lectin Concanavalin A. In addition, as native proteins recombinants Apa and PstS1 were secreted to the culture medium in contrast with LprG that was retained in the cell wall.
Together these results, point out R. erythropolis, as a new host for expression of M. tuberculosis glycoproteins.
KeywordsRhodococcus erythropolis Recombinant glycoproteins Posttranslational modification Mycobacterium tuberculosis
According to Worth Health Organization, tuberculosis claims about 2 million lives every year with almost one-third of the human population infected with M. tuberculosis, a microorganism that develops resistance to virtually all new drugs produced to fight it. Inadequate dosing and incomplete treatment regimens, together with the ability of the bacilli to cause latent infections that are tolerant of currently used drugs, have contributed to the rise of multidrug-resistant tuberculosis . While intensive research efforts are addressing the pathogenesis, new drugs and vaccines are also necessary to explore into conceptual novel approaches for tuberculosis control. Studies of the role of M. tuberculosis molecules involved in host bacteria interactions identified a number of immunodominant mycobacterial proteins which undergo a process of posttranslational modifications such as glycosylation, lipoylation and methylation that provide important immunological properties [2–7]. Thus, these proteins are leading candidates for vaccine development. However, progress in this field has been hampered by the unavailability to obtain large quantities of recombinant modified extracellular proteins. At date, only a few M. tuberculosis proteins with posttranslational modifications have been expressed in Mycobacterium smegmatis and Streptomyces lividans since the recombinant proteins obtained in E. coli cannot be modified [2, 8–10].
Based on the high percentages of homology detected between putative lipoglycoproteins of M. tuberculosis and Rhodococcus spp. RHA1 as well as with a key enzyme for O-mannosylation, the O-mannosyl transferase, we envisioned Rhodococcus spp. as a candidate for expression of M. tuberculosis recombinant glycoproteins . Rhodococcus spp. is a GC-high content bacterium, which metabolizes a wide range of compounds and represents a genus of considerable industrial interest . In the present work, we investigated the feasibility of R. erythropolis as a host for the recombinant production of M. tuberculosis glycoproteins, Apa and the lipoglycoproteins PstS1 and LprG. All these proteins interact with molecules of innate immune system and play an important role in the induction of both cellular and antibody responses against M. tuberculosis. Apa is an Alanine/Proline rich antigen of 45/47 kDa and a potent inductor of T cell immune response which dependent of the O-mannosylation status [2, 3]. This protein together with PstS1 was the first glycoprotein described in M. tuberculosis . PstS1 a 38 kDa is an immunodominant mannosylated lipoprotein (Lpp) and is also a phosphate transporter [13–15]. Disruption of pstS1 gene reduces the in vivo multiplication of M. tuberculosis . LprG a 27 kDa mannosylated Lpp, was found in the cell membrane of M. tuberculosis and Mycobacterium bovis [17, 18]. This protein is considered a virulence factor, since a knockout of lprG gene has proved to be attenuated in virulence in a mouse tuberculosis model . In addition, all the proteins mentioned above, interact with the host through their glycan structures. Both Apa and LprG are ligands for macrophage and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) [3, 20, 21] and Apa and PstS1 interact with macrophage mannose receptor (MR) [3, 22,]. Apa also binds to the pulmonary surfactant protein A, a member of C-type lectins from the innate immune system, this interaction is calcium- and mannose-dependent. Indeed all these molecules; DC_SIGN, MR and surfactant protein A have been shown to bind mycobacteria and facilitate their entry into phagocytes [20–23]. LprG and PstS1 interact with Toll-like receptors (TLR); however while the interaction of PstS1 through both TLR-2 and TLR-4 induces the activation of pathways, which play an essential role in tumor necrosis factor alpha (TNF-α) and interleukine 6 (IL-6) expression during mycobacterial infection , the interaction of LprG with TLR-2 inhibits Major histocompatibility complex class II antigen processing in human macrophages . More recently, it was found that carbohydrate moieties were required for activation of TLR-2 by LprG to stimulate or inhibit T cell activation .
Because of the importance of M. tuberculosis antigens posttransduccionally modified, the availability of heterologous expression systems is a tool that will allow a deeper understanding of the role these proteins play in the pathogenesis of the disease.
Bacterial strains and culture conditions
Escherichia coli TOP10F′ (Invitrogen, USA) used for cloning was grown in Luria-Bertani broth (LB) (Difco, MI, USA). R. erythropolis strain L88, a lysozyme sensible mutant was grown to 26 °C in the same culture medium used for E coli. This bacterium was used as a host for recombinants thiostrepton induced (pTip-QC1) and constitutive (pNit-QC1) plasmids [26–28].
Cloning of M. tuberculosis apa, pstS1, and lprG codificant sequences in R. erythropolis
The complete coding regions of the apa, pstS1 and lprG were amplified by PCR with the high fidelity DNA polymerase Pfx (Invitrogen) from M. tuberculosis H37Rv genomic DNA with the following oligonucleotide primers: ApaRhoFo: 5′-CATCAGGTGGACCCCAACTTGAC-3′ and ApaRhoRv, 5′-GAGGATCCGGCCGGTAAGGTCCGCTGC-3′ (BamHI site in bold); PstS1RhoFo: 5′-AAAATTCGTTTGCATACGCTGTTGG-3′ and PstS1RhoRv5′-GAGGATCCGCTGGAAATCGTCGCGATCAAC-3′ (BamHI site in bold); LprGRhoFo: 5′-CGGACCCCCAGACGCCAC-3′ and LprGRhoRv: 5′-GCAAGATCTGCTCACCGGGGGCTTCGTG-3′ (BglII site in bold). PCR products, apa (980 bp), pstS1 (1127 bp) and lprG (714 bp) were cloned into the pTip-QC1 and pNit-QC1 vectors as follow: plasmids were digested with NcoI, 5′ NcoI overhangs were filled using T4 DNA polymerase (Thermo Scientific, USA) then, plasmids were digested with BglII and gel purified. Purified PCR product of apa and pstS1 ware digested with BamHI and cloned into the vectors to generate pTip-QC1-apa and pNit-QC1-apa; pTip-QC1-pstS1 and pNit-QC1-pstS1 respectively. PCR product of lprG was digested with BglII and ligated into the vectors to generate pTip-QC1-lprG and pNit-QC1-lprG. The identities and orientation of the inserts were confirmed by restriction analysis and DNA-sequencing. All the recombinant plasmids purified from E. coli were used to transform R. erythropolis L88 strain by electroporation as described elsewhere for mycobacteria . Transformed cells were selected in LB agar plates supplemented with 34 μg/ml of chloramphenicol (Chl) and incubated at 26 °C.
Expression and purification Apa, PstS1 and LprG C-terminal Hexahistidine-tagged proteins in R. erythropolis
A single R. erythropolis recombinant colony obtained of each pTip-QC1 and pNit-QC1 derivated vectors was grown overnight (ON) in 5 ml of LB broth supplemented with 34 μg/ml of Chl (LB-Chl) at 26 °C and 200 revolution per minute (rpm). The next day, small-scale expressions of recombinant Apa (rRhoApa), PstS1 (rRhoPstS1) and LprG (rRhoLprG) were performed by diluted ON cultures 1:100 in 50 ml of LB-chl. Cells transformed with constitutive pNit-QC1 recombinant vector were grown for 48 h at 26 °C at 200 rpm. Expression of recombinant proteins in cells transformed with pTip-QC1 vectors, were induced with 1 μg/ml of thiostrepton (Sigma) at 24 h of culture and then bacteria were grown for 24 more hours.
Cells were harvested by centrifugation at 3500×g for 15 min at 4 °C. Cell pellet was resuspended in lysis buffer (50 mM Tris–HCl, 50 mM NaCl, 1 mM DDT, pH 8.0), and bacteria was disrupted by sonication on ice during 15 min with cycles of 1 min and 1 min rest at 15–20% of potency in a Virsonic 550 sonicator (VirTis). After that, sample was centrifuged at 11000×g for 15 min at 4 °C to obtain the soluble extract (SE) and the insoluble fraction (IF). This fraction, was then washed twice with 1% Triton X-100 in phosphate buffered saline (PBS) and once only with PBS. After that, sample was solubilized in sample buffer (10 mM Tris–HCl, 50 mM NaCl, 5 mM imidazol, pH 8.0) with 8 M of urea and the mixture was stirred at room temperature (RT) for 20 min.
Cultures supernatant (CS) was precipitated with 90% of saturated ammonium sulphate solution at 4 °C, proteins were collected by centrifugation at 14000×g for 30 min at 4 °C. Obtained pellets were re-suspended in PBS and dialyzed against this same buffer for elimination of ammonium sulphate. Presence of recombinant proteins in the different obtained fractions was verified by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and by Western blot assay with an anti-Hexahistidine Horseradish peroxidase antibody (anti-His6-HRP) (Roche).
rRhoApa, rRhoPstS1 and rRhoLprG were purified from clarified SE, IF and CS fractions using an AKTÄ Prime System (GE Healthcare) with 1 ml, HistrapMT column (GE Healthcare). For SE and CS fraction after washing and equilibration of Ni–NTA column with sample buffer, sample was loaded and then the column was washed, with wash buffer (50 mM Tris–HCl, 50 mM NaCl, 25 mM imidazol, pH 8.0). Protein was eluted with elution buffer (10 mM Tris–HCl, 50 mM NaCl, 500 mM imidazol, pH 8.0) at 1 ml/min, by using a gradient (0–100% of elution buffer) and fractions displaying the recombinant proteins were pooled and dialyzed to eliminated the imidazol. In the case of IF, protein was purified in denaturing condition, all employed buffers contained 8 M urea and fractions displaying the recombinant proteins were pooled and dialyzed against decreasing urea concentrations. The presence of purified recombinant proteins was monitored by SDS-PAGE. The amount of protein was quantified by the modified Lowry method and proteins were stored at −70 °C until needed.
Western blot assays and ligand blotting assay
Purified recombinant proteins from R. erythropolis SE, IF and CS fractions, were resolved on a 12% SDS-PAGE, transferred to a Polyvinylidene fluoride (PVDF) membrane and visualized by Coomassie brilliant blue R-250 staining. All membranes were blocked with 3% bovine serum albumin (BSA) in PBS at RT for 1 h. After three washes with PBS containing 0.05% Tween 20 (PBS-T), the presence of purified recombinant proteins from R. erythropolis cell fractions and CS were identified by Western blot assay with specific antibodies. Rabbit polyclonal antibodies raised against rRhoPstS1 and rRhoLprG  were diluted 1:500 in PBS-T and membranes were incubated for 1 h at RT in constant agitation. For specific detection of rRhoApa, membranes were incubated for 1 h with anti-Apa 6A3 monoclonal antibody (6A3 mAb) , diluted 1:500 in PBS-T/BSA. After several washes with PBS-T, membranes were incubated for 1 h with Protein A-HRP (Zymed) diluted 1:2000 in PBS-T for detection of polyclonal rabbit anti-sera and with anti-mouse IgG-HRP antibody (Invitrogen) diluted 1:2000 in PBS-T for detection of 6A3 mAb. Glycosylation of the recombinant proteins was determined by ligand blotting assay using the lectin Concanavalin A-HRP (Con A-HRP) (Sigma). Membranes were incubated with shaking ON at 23 °C with ConA-HPR diluted 1:1000 in incubation buffer (1 mM NaCL, 1 mM MgCL, and 1 mM MnCL) in presence or not of 0.3 M of methyl-α-d-mannopyranoside (Sigma). After incubation of membranes with the indicated primary and secondary antibody or ConA-HRP, membranes were washed with PBS-T, and developed with 3 mg/ml of 3,3-diaminobenzidine (DAB) (Sigma) in PBS with 1:1000 dilution of 30% of hydrogen peroxide.
Expression and purification of rRhoApa
rRhoApa was similarly expressed from either R. erythropolis transformed with pTip-QC1-apa or pNit-QC1-apa vectors. Histidine-tagged proteins were found in SE, IF and CS fractions as detected with the anti-His6-HRP (Data not shown).
Expression and purification of rRhoPstS1
rRhoPstS1 was not expressed from R. erythropolis transformed with induced vector pTip-QC1-pstS1. Recombinant proteins obtained from bacteria transformed with constitutive pNit-QC1-pstS1 vector were identified in SE, IF and CS fractions with anti-His6-HRP (Data not shown).
Expression and purification of M. tuberculosis rRhoLprG
Yields of purified proteins
Summary production of recombinant glycoproteins in R. erythropolis
Purified proteina from R. erythropolis transformed with
Total purified protein (mg) from soluble extract
Total purified protein (mg) from insoluble fraction
Total purified protein (mg) from culture supernatant
0.355 ± 0.07
0.334 ± 0.06
0.269 ± 0.042
0.356 ± 0.09
0.349 ± 0.09
0.240 ± 0.06
0.403 ± 0.04
0.399 ± 0.05
0.106 ± 0.012
0.011 ± 0.002
0.019 ± 0.01
0.017 ± 0.004
0.016 ± 0.002
In this work, the coding regions corresponding to immature mycobacterial glycoproteins were amplified from M. tuberculosis H37Rv genomic DNA and cloned in both R. erythropolis pNit-QC1 (constitutive) and pTip-QC1 (thiostrepton inducible) expression vectors. The positive signal obtained with Con A in ligand blotting assays showed that Apa, PstS1and LprG the studied proteins were mannosylated, confirming this result that R. erythropolis possess the machinery to mannosylate proteins from M. tuberculosis. Although these proteins had been expressed in different host: all of them in E. coli [2, 7], PstS1 in M. smegmatis  and Apa in M. smegmatis and M. bovis BCG [2, 31], yields had been only reported for Apa produced in S. lividans. Vallin et al.  obtained 80 mg/l of purified rApa from CS and Gamboa-Suasnavart et al.  reported a higher production of CS rApa in coiled and in baffled flasks 7.44 ± 0.15 g/l than in conventional flasks 4.02 ± 0.08 g/l. From these results is clear that the production of rRhoApa from CS is lower that rApa obtained from CS of S. lividans. The evaluation of both recombinant proteins in a tuberculosis animal model will be important to define their antigenic and immunogenic potential.
Among the M. tuberculosis glycoproteins, Apa has been one of the most studied; this molecule is secreted to the culture medium as a double band of 47/45 kDa, through double Arginine translocase exportation system . Their glycosylation sites determined by Dobos et al.  were located in Threonine (T), T10, T18 and T27 in N-terminus and in T277 in C-terminus. Furthermore, studies by Horn et al.  suggested that Apa double band is the result of proteolytic cleavage of the protein between Proline275 and T276, the calculated mass of the fragment devoid of mannose was 27,616 Da and could correspond to the C-terminal truncated peptide (1–275). Purified rRhoApa from CS was found as a unique band; however when the CS crude extract was incubated with 6A3 mAb, two bands of 47/45 kDa were seen. An explanation is that Apa could being processes in the C-terminus and due to the loss of the Hexahistidine-tag, only one band was purified. The not reactivity of the lower band with Con A in CS crude extract could be due to changes in glycosylation pattern as was observed from Apa recombinant expressed in S. lividans .
Both PstS1 and LprG are Lpp which are predicted to be localized on the cell wall, through their acyl chains. The N-terminal signal sequence of these molecules is distinguishable by the presence of a lipobox motif that includes an invariant Cysteine at the −1 position of the cleaved mature protein. However, as native, rRhoPstS1 was found in CS . It is possible that as has been described for some Lpp of Bacillus subtilis, mycobacterial Lpp being consistently released from membrane through a proteolytic “shaving”. The most important determinant for Lpp release in B. subtilis seems to be on Glycine2 (G) position of the mature Lpp, whereas a Serine (S) on this position seems more important for membrane retention . Interestingly, N-terminal sequence of native PstS1 released to CS showed a cleavage site between G1 and S2 position of the cleaved mature protein (Unpublished data).
It is worth of mention, that in addition to be very close genetically related to M. tuberculosis , Rhodococcus spp. in contrast with other actinomycetes have some advantages for expression of heterologous proteins such as: recombinant proteins are not affected by proteases activity and because the bacteria do not undergo a cellular differentiation, they grow very well in standard LB medium.
The importance of mannosylation in M. tuberculosis proteins is growing, and the role of glycans in host-pathogen interaction as well as the modulation of the immune response made them as important targets in the fight against tuberculosis.
Results obtained concerning heterologous production of recombinant M. tuberculosis glycoproteins, demonstrated the potential of R. erythropolis as a valuable host for the production of recombinant proteins from M. tuberculosis.
CE conceived the idea for the study and together with AJV designed the experiments. CP, PM and AJV performed the experiments. CE Analyzed the data and wrote the manuscript. AJV and CP revised the manuscript. All authors read and approved the final manuscript.
Rhodococcus erythropolis pNit-QC1 and pTip-QC1 expression vectors and L88 strain were kindly provided for Dr. Tomohiro Tamura (Proteolysis and Protein Turnover Research Group, Research Institute of Genome-Based Biofactory, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba-Higashi, Tsukuba, Japan). We thank Erika Segura for technical assistance and Manuela Irene for reviewing the English version of the manuscript. Funding resources: The project is supported by PAPIIT-UNAM: IN208712-2. Universidad Nacional Autónoma de México. We also thank the institucional program “Nuevas Alternativas de Tratamiento para Enfermedades Infecciosas” (NUATEI) of the Instituto de Investigaciones Biomédicas UNAM.
The authors declare that they have no competing interests.
Availability of data and materials
Additional data is available upon request. The biological material created in this for the expression of the Apa, PstS1 and LprG proteins are all available upon request from CE (firstname.lastname@example.org) at the Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, C.P. 04510, México, D.F. México. Phone: (5255)56223860.
Consent for publication
All authors read, approved the final manuscript and approve its publication.
The project is supported by PAPIIT-UNAM: IN208712-2. Universidad Nacional Autónoma de México.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Hoagland DT, Liu J, Lee RB, Lee RE. New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Adv Drug Deliv Rev. 2016;102:55–72.View ArticleGoogle Scholar
- Horn C, Namane A, Pescher P, Rivière M, Romain F, Puzo G, Bârzu O, Marchal G. Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern. J Biol Chem. 1999;274:32023–30.View ArticleGoogle Scholar
- Nandakumar S, Kannanganat S, Dobos KM, Lucas M, Spencer JS, Fang S, McDonald MA, Pohl J, Birkness K, Chamcha V, Ramirez MV, Plikaytis BB, Posey JE, Amara RR, Sable SB. O-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protection. PLoS Pathog. 2013;9(10):e1003705. doi:https://doi.org/10.1371/journal.ppat.1003705.View ArticleGoogle Scholar
- Sieling PA, Hill PJ, Dobos KM, Brookman K, Kuhlman AM, Fabri M, Krutzik SR, Rea TH, Heaslip DG, Belisle JT, Modlin RL. Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation. J Immunol. 2008;180:5833–42.View ArticleGoogle Scholar
- Becker K, Sander P. Mycobacterium tuberculosis lipoproteins in virulence and immunity-fighting with a double-edged sword. FEBS Lett. 2016;. doi:https://doi.org/10.1002/1873-3468.12273.Google Scholar
- Temmerman S, Pethe K, Parra M, Alonso S, Rouanet C, Pickett T, Drowart A, Debrie AS, Delogu G, Menozzi FD, Sergheraert C, Brennan MJ, Mascart F, Locht C. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat Med. 2004;10:935–41.View ArticleGoogle Scholar
- González-Zamorano M, Mendoza-Hernández G, Xolalpa W, Parada C, Vallecillo AJ, Bigi F, Espitia C. Mycobacterium tuberculosis glycoproteomics based on ConA-lectin affinity capture of mannosylated proteins. J Proteome Res. 2009;8:721–33.View ArticleGoogle Scholar
- Torres A, Juárez MD, Cervantes R, Espitia C. Molecular analysis of Mycobacterium tuberculosis phosphate specific transport system in Mycobacterium smegmatis. Characterization of recombinant 38 kDa (PstS-1). Microb Pathog. 2001;30:289–97.View ArticleGoogle Scholar
- Lara M, Servín-González L, Singh M, Moreno C, Cohen I, Nimtz M, Espitia C. Expression, secretion, and glycosylation of the 45- and 47-kDa glycoprotein of Mycobacterium tuberculosis in Streptomyces lividans. Appl Environ Microbiol. 2004;70:679–85.View ArticleGoogle Scholar
- Shin AR, Lee KS, Lee JS, Kim SY, Song CH, Jung SB, Yang CS, Jo EK, Park JK, Paik TH, Kim HJ. Mycobacterium tuberculosis HBHA protein reacts strongly with the serum immunoglobulin M of tuberculosis patients. Clin Vaccine Immunol. 2006;13:869–75.View ArticleGoogle Scholar
- McLeod MP, Warren RL, Hsiao WW, Araki N, Myhre M, Fernandes C, Miyazawa D, Wong W, Lillquist AL, Wang D, Dosanjh M, Hara H, Petrescu A, Morin RD, Yang G, Stott JM, Schein JE, Shin H, Smailus D, Siddiqui AS, Marra MA, Jones SJ, Holt R, Brinkman FS, Miyauchi K, Fukuda M, Davies JE, Mohn WW, Eltis LD. The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. Proc Natl Acad Sci USA. 2006;103:15582–7.View ArticleGoogle Scholar
- Espitia C, Mancilla R. Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens. Clin Exp Immunol. 1989;77:378–83.Google Scholar
- Espitia C, Elinos M, Hernández-Pando R, Mancilla R. Phosphate starvation enhances expression of the immunodominant 38-kilodalton protein antigen of Mycobacterium tuberculosis: demonstration by immunogold electron microscopy. Infect Immun. 1992;60:2998–3001.Google Scholar
- Lefèvre P, Braibant M, de Wit L, Kalai M, Röeper D, Grötzinger J, Delville JP, Peirs P, Ooms J, Huygen K, Content J. Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J Bacteriol. 1997;179:2900–6.View ArticleGoogle Scholar
- Espitia C, Cervera I, González R, Mancilla R. A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation. Clin Exp Immunol. 1989;77:373–7.Google Scholar
- Peirs P, Lefèvre P, Boarbi S, Wang XM, Denis O, Braibant M, Pethe K, Locht C, Huygen K, Content J. Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence. Infect Immun. 2005;73:1898–902.View ArticleGoogle Scholar
- Bigi F, Espitia C, Alito A, Zumarraga M, Romano MI, Cravero S, Cataldi A. A novel 27 kDa lipoprotein antigen from Mycobacterium bovis. Microbiology. 1997;143(Pt 11):3599–605.View ArticleGoogle Scholar
- Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol. 2004;173:2660–8.View ArticleGoogle Scholar
- Hovav AH, Mullerad J, Maly A, Davidovitch L, Fishman Y, Bercovier H. Aggravated infection in mice co-administered with Mycobacterium tuberculosis and the 27-kDa lipoprotein. Microbes Infect. 2006;8:1750–7.View ArticleGoogle Scholar
- Carroll MV, Sim RB, Bigi F, Jäkel A, Antrobus R, Mitchell DA. Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG. Protein Cell. 2010;1:859–70.View ArticleGoogle Scholar
- Pitarque S, Herrmann JL, Duteyrat JL, Jackson M, Stewart GR, Lecointe F, Payre B, Schwartz O, Young DB, Marchal G, Lagrange PH, Puzo G, Gicquel B, Nigou J, Neyrolles O. Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. Biochem J. 2005;392(Pt 3):615–24.View ArticleGoogle Scholar
- Esparza M, Palomares B, García T, Espinosa P, Zenteno E, Mancilla R. PstS-1, the 38-kDa Mycobacterium tuberculosis glycoprotein, is an adhesin, which binds the macrophage mannose receptor and promotes phagocytosis. Scand J Immunol. 2015;81:46–55.View ArticleGoogle Scholar
- Ragas A, Roussel L, Puzo G, Rivière M. The Mycobacterium tuberculosis cell-surface glycoprotein Apa as a potential adhesin to colonize target cells via the innate immune system pulmonary C-type lectin surfactant protein A. J Biol Chem. 2007;282:5133–42.View ArticleGoogle Scholar
- Jung SB, Yang CS, Lee JS, Shin AR, Jung SS, Son JW, Harding CV, Kim HJ, Park JK, Paik TH, Song CH, Jo EK. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through toll-like receptors 2 and 4 in human monocytes. Infect Immun. 2006;74:2686–96.View ArticleGoogle Scholar
- Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding CV. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol. 2001;167:910–8.View ArticleGoogle Scholar
- Nakashima N, Tamura T. A novel system for expressing recombinant proteins over a wide temperature range from 4 to 35 °C. Biotechnol Bioeng. 2004;86:136–48.View ArticleGoogle Scholar
- Mitani Y, Meng X, Kamagata Y, Tamura T. Characterization of LtsA from Rhodococcus erythropolis, an enzyme with glutamine amidotransferase activity. J Bacteriol. 2005;187:2582–91.View ArticleGoogle Scholar
- Nakashima N, Tamura T. Isolation and characterization of a rolling-circle-type plasmid from Rhodococcus erythropolis and application of the plasmid to multiple-recombinant-protein expression. Appl Environ Microbiol. 2004;70:5557–68.View ArticleGoogle Scholar
- Parish T, Stoker NG. Electroporation of mycobacteria. In: Parish T, Stoker NG, editors. Mycobacteria protocols. Methods in molecular biology. Totowa: Humana Press Inc; 1998. p. 129–44.View ArticleGoogle Scholar
- Espitia C, Espinosa R, Saavedra R, Mancilla R, Romain F, Laqueyrerie A, Moreno C. Antigenic and structural similarities between Mycobacterium tuberculosis 50- to 55-kilodalton and Mycobacterium bovis BCG 45- to 47-kilodalton antigens. Infect Immun. 1995;63:580–4.Google Scholar
- Satchidanandam V, Kumar N, Jumani RS, Challu V, Elangovan S, Khan NA. The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG. PLoS Pathog. 2014;10:1–15.View ArticleGoogle Scholar
- Vallin C, Ramos A, Pimienta E, Rodríguez C, Hernández T, Hernández I, Del Sol R, Rosabal G, Van Mellaert L, Anné J. Streptomyces as host for recombinant production of Mycobacterium tuberculosis proteins. Tuberculosis (Edinb). 2006;86:198–202.View ArticleGoogle Scholar
- Gamboa-Suasnavart RA, Valdez-Cruz NA, Cordova-Dávalos LE, Martínez-Sotelo JA, Servín-González L, Espitia C, Trujillo-Roldán MA. The O-mannosylation and production of recombinant APA (45/47 KDa) protein from Mycobacterium tuberculosis in Streptomyces lividans is affected by culture conditions in shake flasks. Microb Cell Fact. 2011;10:1–15.View ArticleGoogle Scholar
- Marrichi M, Camacho L, Russell DG, DeLisa MP. Genetic toggling of alkaline phosphatase folding reveals signal peptides for all major modes of transport across the inner membrane of bacteria. J Biol Chem. 2008;283:35223–35.View ArticleGoogle Scholar
- Dobos KM, Khoo KH, Swiderek KM, Brennan PJ, Belisle JT. Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. J Bacteriol. 1996;178:2498–506.View ArticleGoogle Scholar
- Tjalsma H, van Dijl JM. Proteomics-based consensus prediction of protein retention in a bacterial membrane. Proteomics. 2005;5:4472–82.View ArticleGoogle Scholar